17
©2011 MFMER | slide-1 Assessment of Renal Fibrosis Using Magnetization Transfer MRI Lilach O. Lerman, MD, PhD Division of Nephrology and Hypertension Mayo Clinic, Rochester, MN

Assessment of Renal Fibrosis Using Magnetization Transfer MRI...©2011 MFMER | slide-1 Assessment of Renal Fibrosis Using Magnetization Transfer MRI Lilach O. Lerman, MD, PhD Division

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

  • ©2011 MFMER | slide-1

    Assessment of Renal Fibrosis

    Using Magnetization Transfer MRI

    Lilach O. Lerman, MD, PhD Division of Nephrology and Hypertension Mayo Clinic, Rochester, MN

  • ©2011 MFMER | slide-2

    Development of Renal fibrosis • Consistent predictor of an irreversible loss of renal

    function • Accumulation of extracellular matrix is a common

    denominator of progressive fibrosis •  macromolecules like fibronectin, collagens type I, III, and

    IV, elastin, thrombospondin, vitronectin, laminin, proteoglycans, glycoproteins

    • A noninvasive, direct, specific method is needed •  improve early diagnosis and gauge progression of renal

    injury or success of therapy

  • ©2011 MFMER | slide-3

    Magnetization transfer imaging (MTI) •  Molecular MRI based on co-

    existence of 2 tissue proton pools: 1.  Observable, free water pool

    (freedom to perfuse / diffuse) 2.  Invisible, restricted water pool

    (bound to local molecules).

    •  An off-resonance MT can render restricted molecules ‘visible’

    •  Longitudinal magnetization of restricted water molecules is saturated using a selective radio-frequency (RF) pulse

  • ©2011 MFMER | slide-4

    Evaluation of MTI contrast

    •  Due to their saturation, exchanged molecules do not participate in the MR signal of the free water pool -  a detectable decrease in free water signal at the readout -  proportional to restricted pool size and exchange rate

    •  In scar tissue collagen is the main target macromolecule

    •  Optimal MTI parameters depend on -  Collagen type -  Tissue type -  Magnetic field

  • ©2011 MFMER | slide-5

    Experimental Validation

    7T and 16.4T: • Ex vivo: excised mouse kidneys •  In vitro: collagen phantom •  In vivo: unilateral murine renal artery stenosis (RAS) • Longitudinal: at 2, 4, & 6 wks of unilateral murine RAS 3T: •  In vitro: collagen phantom •  In vivo: unilateral swine RAS •  In vivo: prediction/detection of reversal of swine RAS

    • Hypothesis: MTI can detect renal fibrosis -  correlate with kidney function and oxygenation

    in renovascular disease

  • ©2011 MFMER | slide-6

    MTR Maps of Murine RAS Kidneys

    Baseline MT-Weighted MTR Map

    1.0

    0.8

    0.6

    0.4

    0.2 0

  • ©2011 MFMER | slide-7

    1.0

    0.8

    0.6

    0.4

    0.2 0

    STK Sham

    Trichrome Sirius Red under Polarized Light MTR Map

    Fibrosis Necrosis Pelvis

    MTI for Fibrosis Measurement in Murine RAS

    •  Jiang K, et al… Lerman LO. Radiology: 160566, 2016.

  • ©2011 MFMER | slide-8

    Baseline 2 Weeks 4 Weeks 6 Weeks 0

    1.0

    0.2

    0.4

    0.6

    0.8

    Fibrosis Necrosis Edema MTI vs. BOLD-MRI

    MTI

    BOLD

    Jiang K, et al… Lerman LO. Radiology: 160566, 2016.

  • ©2011 MFMER | slide-9

    3.0 Tesla MRI

  • ©2011 MFMER | slide-10

    MTI with Moderate and Severe RAS

    Jiang K, et al. Invest Radiol 52: 686-692, 2017

    50#

    60#

    70#

    80#

    90#

    1# 2# 3# 4# 5# 6# 7# 8# 9# 10# 11# 12# 13# 14# 15# 16#

    MTR

    #(%)#

    Cortex ############Medulla##############################Cortex####################Medulla#1000#Hz# # # ###############600#Hz#

    0#

    1.4#

    1000#Hz#

    600#Hz#

    Control# Moderate#Stenosis#a" Severe#Stenosis#

    b"P=0.001"

    P

  • ©2011 MFMER | slide-11

    Correlation between MTR and Renal Fibrosis

    Control ARAS y = 1.14x + 67.28

    r = 0.75 P

  • ©2011 MFMER | slide-12

    0.5

    0.55

    0.6

    0.65

    0.7

    0.75

    0.8

    Baseline 50% 75% 100% Recovery

    MTR

    0.6

    0.65

    0.7

    0.75

    0.8

    0.85

    0.9

    Baseline 50% 75% 100% Recovery

    MTR

    MTI: Hemodynamic Stability

    Baseline 50% 75% 100% Recovery

    •  STK cortical MTR largely stable over a range of RBF •  slight drop at recovery

    •  A transient decrease in CLK MTR, due to increased fluid?

    0

    1.4

    STK CLK

    * *

    * * *P

  • ©2011 MFMER | slide-13

    MTI in Predicting Renal Recovery

    •  Pigs studied after 6 wks of RAS and again 4 wks after PTRA•  ΔMTR correlates well with renal ΔGFRn

    y = -127.5x + 0.2 r = 0.75

    P = 0.072

    -10

    -5

    0

    5

    10

    -0.04 -0.02 0.00 0.02 0.04 0.06

    ΔG

    FRn (

    ml/1

    00m

    l/min

    )

    ΔMTR

    y = -135.6x - 1.6 r = 0.87

    P = 0.028

    -10

    -0.06 -0.04 -0.02 0.00 0.02 0.04

    ΔG

    FRn (

    ml/1

    00m

    l/min

    ) ΔMTR

    Cortex Medulla

    •  Jiang K, et al. In Progress

  • ©2011 MFMER | slide-14

    Quantitative MT (qMT)

  • ©2011 MFMER | slide-15

    0

    2

    4

    6

    1

    f (%

    )

    Control RAS

    Control (n=5) RAS (n=8)

    In Vivo qMT at 16.4T: Renal Cortex

    P=0.021 y = 0.12x + 4.01

    r = 0.88 P

  • ©2011 MFMER | slide-16

    -100

    100Hz

    0

    1.5

    1.0

    3.0sB0 Map B1 Map T1 Map

    0

    2

    4

    6

    8

    10

    12

    CLK STK CLK STK

    f (%

    )

    Cortex Medulla

    CLK STK

    qMT Fitting Bound Pool Fraction f

    Feasibility of qMT in Swine Kidney at 3.0 T

    •  Jiang K, et al. In Progress

  • ©2011 MFMER | slide-17

    Conclusions: MTI for Detection of Kidney Fibrosis • In vivo MTR (16.4T, 7T, 3T) correlates well with

    renal fibrosis determined by histology May allow detection/monitoring of renal disease

    • May allow quantitative reproducible measures • Need to establish sensitivity and specificity;

    application to other models • Cost, availability, contraindications, vendor

    dependence, application in human subjects?